820 THERAPEUTIC DRUG MONITORING OF TELAPREVIR IN CHRONIC HEPATITIS C PATIENTS RECEIVING TELAPREVIR-BASED TRIPLE THERAPY IS USEFUL FOR PREDICTING VIROLOGICAL RESPONSE AND AVOIDING TOXIC DRUG-EXPOSURE

2013 ◽  
Vol 58 ◽  
pp. S336
Author(s):  
N. Furusyo ◽  
E. Ogawa ◽  
M. Murata ◽  
K. Toyoda ◽  
H. Ohnishi ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Therapeutic Drug Monitoring ◽  
Triple Therapy ◽  
Drug Monitoring ◽  
Virological Response ◽  
Drug Exposure ◽  
Therapeutic Drug ◽  
Toxic Drug ◽  
Chronic Hepatitis C Patients

scholarly journals Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease

2016 ◽  
Vol 65 (5) ◽  
pp. 1063-1065 ◽  
Author(s):  
Julien Vionnet ◽  
Anne-Catherine Saouli ◽  
Manuel Pascual ◽  
Fabien Stucker ◽  
Laurent Arthur Decosterd ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Therapeutic Drug Monitoring ◽  
Renal Disease ◽  
Chronic Hepatitis C ◽  
Drug Monitoring ◽  
Therapeutic Drug ◽  
Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document